PRSS23 and congestive heart failure: As a result, exosomal miR‐320a may function as a specific target for therapeutic strategies for CHF.[124] Moreover, human umbilical cord mesenchymal stem cells (hucMSCs) release miR-1246 during CHF and serine protease 23 (PRSS23) is a specific target of miR-1246.